PRESS RELEASE published on 04/11/2024 at 11:23, 7 months 13 days ago Cairn Homes Plc: Holding(s) in Company Cairn Homes Plc notified of a major holding reaching 4.11% voting rights by abrdn plc affiliated entities. Details of the notification provided Voting Rights Cairn Homes Plc Major Holding CRN Abrdn Plc
BRIEF published on 04/11/2024 at 08:05, 7 months 13 days ago Cairn Homes Plc Announces Share Buyback on Euronext Dublin and London Stock Exchange London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Goodbody Stockbrokers
PRESS RELEASE published on 04/11/2024 at 08:00, 7 months 13 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase of 100,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange. The shares will be cancelled as part of the share buyback program London Stock Exchange Ordinary Shares Share Buyback Program Cairn Homes Plc Euronext Dublin
BRIEF published on 04/10/2024 at 18:48, 7 months 13 days ago JPMorgan Adjusts Holdings in Cairn Homes Plc Voting Rights Cairn Homes Plc Financial Instruments JPMorgan Asset Management Investment Changes
PRESS RELEASE published on 04/10/2024 at 18:43, 7 months 13 days ago Cairn Homes Plc: Holding(s) in Company Cairn Homes Plc notification of change in total number of voting rights by JPMorgan Asset Management Holdings Inc. on 05 April 2024 Voting Rights Cairn Homes Plc Notification JPMorgan Asset Management Holdings Inc. Change
BRIEF published on 04/10/2024 at 18:38, 7 months 13 days ago Cairn Homes Plc Directors' Share Transactions Announced Tax Liability Market Abuse Regulation Cairn Homes Plc Euronext Dublin Share Disposal
PRESS RELEASE published on 04/10/2024 at 18:33, 7 months 13 days ago Cairn Homes Plc: Director/PDMR Shareholding Cairn Homes Plc directors disclose share transactions to settle tax liabilities. Michael Stanley and Shane Doherty sell shares. Details under EU market abuse regulation Cairn Homes Plc Share Transactions Directors EU Market Abuse Regulation Tax Liabilities
BRIEF published on 04/10/2024 at 08:05, 7 months 14 days ago Cairn Homes Plc Announces Share Buyback Completion London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Capital Management
PRESS RELEASE published on 04/10/2024 at 08:00, 7 months 14 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 98,876 of its ordinary shares for cancellation through its broker Goodbody on Euronext Dublin and London Stock Exchange. Shares bought back at varying prices London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Goodbody Stockbrokers UC
BRIEF published on 04/09/2024 at 16:52, 7 months 14 days ago Cairn Homes Plc Announces Change in Major Holdings Voting Rights Cairn Homes Plc Financial Instruments FIL Limited Market Transparency
Published on 11/22/2024 at 23:55, 1 day 12 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 13 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 13 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 14 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 18 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 19 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 3 days 5 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 17 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 18 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 18 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
